| scholarly article | Q13442814 |
| P2093 | author name string | Amor B | |
| Dougados M | |||
| Boumier P | |||
| P2860 | cites work | Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease | Q33554375 |
| Sulphasalazine in ankylosing spondylitis | Q33556616 | ||
| Sulphasalazine: a 'new' antirheumatic drug | Q40093081 | ||
| Megaloblastic anaemia associated with sulphasalazine treatment | Q66701576 | ||
| Does sulphasalazine cause folate deficiency in rheumatoid arthritis? | Q69870796 | ||
| Sulfasalazine and Ankylosing Spondylitis | Q72592019 | ||
| P433 | issue | 6552 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ankylosing spondylitis | Q52849 |
| P304 | page(s) | 911-914 | |
| P577 | publication date | 1986-10-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients | |
| P478 | volume | 293 |
| Q53993832 | A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis. |
| Q67465264 | Ankylosing spondylitis. Current drug treatment |
| Q33564938 | Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine |
| Q33560570 | Circulating inhibitor bound elastase in patients with ankylosing spondylitis and rheumatoid arthritis and the influence of sulphasalazine treatment |
| Q33866982 | Conventional therapy for Crohn's disease |
| Q77120985 | Current guidelines for the drug treatment of ankylosing spondylitis |
| Q33560695 | Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients |
| Q35537104 | Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial |
| Q35637863 | Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial |
| Q41235897 | Enumeration of IgA producing cells by the enzyme linked immunospot (ELISPOT) technique to evaluate sulphasalazine effects in inflammatory arthritides |
| Q33564950 | Evaluation of sulphasalazine in the treatment of spondyloarthropathies |
| Q33567171 | Evidence for differential effects of sulphasalazine on systemic and mucosal immunity in rheumatoid arthritis |
| Q36004879 | Juvenile spondyloarthritis treatment recommendations |
| Q38618659 | Newer 5-aminosalicylic acid based drugs in chronic inflammatory bowel disease |
| Q38071925 | Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): a systematic literature review of randomized controlled trials. |
| Q39389171 | Oral Anaerobic Bacteria in the Etiology of Ankylosing Spondylitis |
| Q38499216 | Periodontal pathogens are likely to be responsible for the development of ankylosing spondylitis |
| Q36286209 | Pharmacological treatment of ankylosing spondylitis: a systematic review |
| Q33570182 | Rheumatoid arthritis and gut related lymphocytes: the iteropathy concept |
| Q46309940 | Salazopyrin EN in rheumatoid arthritis. |
| Q72686351 | Sulphasalazine desensitisation in patients with arthritis |
| Q44342666 | Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment |
| Q39466952 | Sulphasalazine in arthritis--an old drug rediscovered |
| Q42538496 | Sulphasalazine in the treatment of children with chronic arthritis |
| Q69370492 | Sulphasalazine versus penicillamine in the treatment of rheumatoid arthritis |
| Q69917377 | T lymphocytes in ankylosing spondylitis and the influence of sulphasalazine treatment |
| Q48628994 | TNFα blockers followed by continuation of sulfasalazine and methotrexate combination: a retrospective study on cost saving options of treatment in Spondyloarthritis |
| Q50119044 | The triggering role of physical injury in the onset of peripheral arthritis in seronegative spondyloarthropathy |
| Q54122126 | Treatment of psoriatic arthritis with sulphasalazine: a one year open study. |
Search more.